Skip to main content

STRYKER CORP

corporate_fare Company Profile

STRYKER CORP

SYK·NYSE·Industrial Applications And Services·CIK 0000310764

Stryker Corporation is a global leader in medical technologies, offering innovative products and services to improve patient and healthcare outcomes. The company impacts over 150 million patients annually. Stryker was incorporated in Michigan in 1946, succeeding a business founded in 1941 by Dr. Homer H. Stryker. Its products are sold in approximately 61 countries through company-owned subsidiaries, branches, and third-party dealers and distributors. Stryker's product portfolio includes surgical equipment and navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, and intensive care disposable products; clinical communication and AI-assisted virtual care platform technology; products for traditional brain and open skull-based surgical procedures; minimally invasive products for acute ischemic and hemorrhagic stroke and venous thromboembolism; implants for joint replacement and trauma surgeries; Mako robotic-arm assisted technology; and other products for various medical specialties. Most products are marketed directly to doctors, hospitals, and other healthcare facilities. The company segregates its operations into two reportable business segments: MedSurg and Neurotechnology, and Orthopaedics.

STRYKER CORP (NYSE:SYK) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors SYK SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Director Ronda Stryker Files Intent to Sell $97 Million in Stock
  • Up to $835M Acquisition of Amplitude Vascular Systems Bolsters Stryker's Medtech Portfolio
  • Stryker Reports Mixed Q1 Results with GAAP Earnings Growth, Cyberattack Impact on Margins, and New Acquisition
  • Stryker's Q1 Adjusted EBITDA Misses Consensus by 33%; JPMorgan Cuts Price Target
  • Influential Director Ronda Stryker Discloses Sale of $174M in Shares

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$25.12B
Net Income
$3.25B
Diluted EPS
$8.40
Op. Cash Flow
$5.04B
Free Cash Flow
$4.28B
Gross Profit
$16.07B
Operating Income
$4.89B
Cash & Equivalents
$4.01B
Total Debt
$15.86B
Debt / Equity
0.71×
Net Margin
12.9%
Shares Outstanding
382.2M sh
Source: 10-K · filed 2026-02-11 · accession 0000310764-26-000010
Browse all tickers starting with S →
$312.2
52-week range · as of 2026-05-27 $281 – $404.87
Market cap
$119.69B
Volume
3.2M (1.1× avg)
3-mo avg 3M
Live data · 2026-06-14 05:16 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SYK - Latest Insights

SYK
May 27, 2026, 8:49 AM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $316.40
Real-time Price: $312.20 info
Change: -$4.20 (-1%) info
Market Cap: $119.685B info
SYK
May 19, 2026, 5:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $307.70
Real-time Price: $312.20 info
Change: +$4.50 (+1%) info
Market Cap: $119.685B info
SYK
May 11, 2026, 11:10 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $281.95
Real-time Price: $312.20 info
Change: +$30.25 (+11%) info
Market Cap: $119.685B info
SYK
May 01, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $294.99
Real-time Price: $312.20 info
Change: +$17.21 (+6%) info
Market Cap: $119.685B info
SYK
Apr 14, 2026, 12:59 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $348.82
Real-time Price: $312.20 info
Change: -$36.62 (-10%) info
Market Cap: $119.685B info
SYK
Apr 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $338.10
Real-time Price: $312.20 info
Change: -$25.90 (-8%) info
Market Cap: $119.685B info
SYK
Apr 09, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $339.99
Real-time Price: $312.20 info
Change: -$27.79 (-8%) info
Market Cap: $119.685B info
SYK
Mar 23, 2026, 1:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $332.85
Real-time Price: $312.20 info
Change: -$20.65 (-6%) info
Market Cap: $119.685B info
SYK
Mar 23, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $334.07
Real-time Price: $312.20 info
Change: -$21.87 (-7%) info
Market Cap: $119.685B info
SYK
Mar 23, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $334.07
Real-time Price: $312.20 info
Change: -$21.87 (-7%) info
Market Cap: $119.685B info
SYK
Mar 12, 2026, 5:27 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $337.00
Real-time Price: $312.20 info
Change: -$24.80 (-7%) info
Market Cap: $119.685B info
SYK
Mar 12, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $337.00
Real-time Price: $312.20 info
Change: -$24.80 (-7%) info
Market Cap: $119.685B info
SYK
Mar 11, 2026, 5:24 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $342.43
Real-time Price: $312.20 info
Change: -$30.23 (-9%) info
Market Cap: $119.685B info
SYK
Mar 11, 2026, 3:03 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $347.79
Real-time Price: $312.20 info
Change: -$35.59 (-10%) info
Market Cap: $119.685B info
SYK
Feb 11, 2026, 11:43 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $359.90
Real-time Price: $312.20 info
Change: -$47.70 (-13%) info
Market Cap: $119.685B info
SYK
Jan 29, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $360.00
Real-time Price: $312.20 info
Change: -$47.80 (-13%) info
Market Cap: $119.685B info